Oruka Therapeutics, Inc. · NASDAQ:ORKA
Goncalves Joana sold 7,947 Oruka Therapeutics, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 15, 2026
On Sep 15, 2026, Goncalves Joana (Chief Medical Officer) sold 7,947 Oruka Therapeutics, Inc. shares at an average US$92.38 for US$734K under a trading plan, leaving 31,771 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 7,947 shares
- Price
- US$92.38 average (US$91.10 to US$95.71)
- Value
- US$734K
- Holding after
- 31,771 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Option exercise | 3,500 | US$6.84 | 36,218 | Direct |
| Sep 15, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 39,718 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 2,384 | US$91.10 | 37,334 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 3,150 | US$92.03 | 34,184 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 1,366 | US$92.99 | 32,818 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 100 | US$94.22 | 32,718 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 947 | US$95.71 | 31,771 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Goncalves Joana
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Goncalves Joana · Aug 17, 2026
- Form 4 · Goncalves Joana · Jul 15, 2026
- Form 4 · Goncalves Joana · Jun 15, 2026
- Form 4 · Goncalves Joana · May 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026